Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus ketorolac for acute pain after closed musculoskeletal limb trauma
IRCT20260824070783N1Phase 3Not yet recruiting
- Sponsor
- Islamic Azad University, Yazd Branch
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Intravenous ketamine with Intravenous ketorolac (2 arms). Primary endpoint: Reduction in pain score from baseline to 30 minutes after drug administration. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ketamineketorolac
Beyond the preview
Go deeper on IRCT20260824070783N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260824070783N1.